Company profile: Gambro
1.1 - Company Overview
Company description
- Provider of medical technology developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Gambro
MediBeacon
HQ: United States
Website
- Description: Provider of optical diagnostic solutions for non-invasive organ function measurement, including the Transdermal GFR Measurement System (TGFR) that assesses kidney function via a fluorescent tracer (Lumitrace) detected through the skin, plus TGFR Sensors and Monitors for real-time data. Also offers novel fluorescent tracer agents and highly engineered transdermal sensors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MediBeacon company profile →
Judo Bio
HQ: United States
Website
- Description: Provider of precision therapeutics targeting specific cell populations to address genetic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Judo Bio company profile →
Allena Pharmaceuticals
HQ: United States
Website
- Description: Provider of non-systemic protein therapeutics to treat metabolic and orphan diseases, engaged in development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allena Pharmaceuticals company profile →
Cadrenal Therapeutics
HQ: United States
Website
- Description: Provider of Tecarfarin, a late-stage novel oral anticoagulant targeting a different metabolic pathway than warfarin for patients with end-stage kidney disease (ESKD) and atrial fibrillation (AFib). Under development for anticoagulation needs of left ventricular assist device (LVAD) patients and those with Antiphospholipid Syndrome (APS), aiming for safer alternatives to warfarin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cadrenal Therapeutics company profile →
Potrero Medical
HQ: United States
Website
- Description: Provider of predictive health technologies developing smart sensors and AI, including the Accuryn Monitoring System for real-time monitoring of urine output, intra-abdominal pressure, and core body temperature to detect acute kidney injury risk; AccuTab software for visualizing and annotating data; and Accuryn SmartFoley catheters designed to reduce CAUTIs by preventing urine backflow.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Potrero Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Gambro
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Gambro
2.2 - Growth funds investing in similar companies to Gambro
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Gambro
4.2 - Public trading comparable groups for Gambro
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →